MorphoSys AG buy Don_Jupp
Start price
28.08.16
/
50%
€38.20
Target price
01.03.17
€55.00
Performance (%)
40.88%
End price
01.03.17
€53.81
Summary
This prediction ended on 01.03.17 with a price of €53.81. The BUY prediction by Don_Jupp for MorphoSys AG saw massive gains of 40.88%. Don_Jupp has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | -1.476% | -1.476% | 262.181% | -16.395% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by Don_Jupp for this prediction
In the thread Morphosys AG diskutieren
Der Trend sollte "aufwärts" sein
(Laufzeit überschritten)